Bay 3713372
MTAP-deleted Solid Tumors
BayerSmall moleculePhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 89/ 100
Competitive context
3 Active assets in the MTAP-deleted Solid Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
s095035 Servier Bio-Innovation LLC | Phase 1/2 | CC |
tng462 Servier Bio-Innovation LLC | Phase 1/2 | CC |
pep08 PharmaEngine | Phase 1 | CC |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →